New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


The golden age of biomedical diagnostics is here

We are entering a golden age of biomedical diagnostics and personalized treatment. The cost of pharmacogenetic testing continues to decline and more insurers are offering coverage for these tests. This will allow clinicians and medical researchers to really drill down into the data to improve patient outcomes and determine in advance what treatment will work best – and which treatments to avoid – for each individual. It’s an exciting time, according to Jonathan Stein, Chief Scientific Officer at Tesis Biosciences.